Sante Holdings

Santé is a healthcare-focused investment firm managing over $1 billion in capital across two primary investment strategies: Santé Ventures and Santé Capital. Founded in 2006, the firm has built a track record of identifying and backing transformative companies at the intersection of healthcare and technology. Operating from a technology-driven investment philosophy, Santé targets opportunities with the potential to improve patient health outcomes while delivering attractive risk-adjusted returns to its investors.

Santé Ventures focuses on privately held companies operating in the Biotech, Medtech, and Healthtech sectors. The team combines deep scientific expertise with extensive healthcare industry experience to identify visionary entrepreneurs and emerging technologies that advance biology, medicine, and health information systems. The firm has launched five successive venture funds since 2007, with Fund V launched in 2024, demonstrating sustained institutional commitment and growth over nearly two decades. Portfolio companies have included late-stage clinical-stage therapeutics and medical device innovators, such as companies developing pan-KRAS inhibitors for oncology, high-intensity focused ultrasound (HIFU) therapies for pancreatic cancer, and next-generation thrombectomy platforms for pulmonary embolism treatment.

Santé Capital represents the firm's public markets strategy, employing a systematic, quantitative approach to investing in publicly traded securities. Central to this strategy is MindRank™, a proprietary software platform that leverages big data analytics, machine learning, and natural language processing to identify mispriced securities and capture investment opportunities within a liquid hedge fund framework. This technology-driven methodology allows Santé Capital to pursue systematic alpha generation in public equity markets.

Collectively, Santé's dual-platform model positions the firm as a full-spectrum healthcare investment manager, spanning early-stage venture capital through public market strategies. The firm's core pillars include generating returns, improving lives, unleashing talent, advancing technology, and pursuing excellence — values that shape both its investment thesis and portfolio management approach. With a history spanning nearly 20 years and a growing portfolio of innovative healthcare companies, Santé serves as a significant capital allocator within the life sciences and health technology investment ecosystem.